There’s no better time to be working with us. The Australian Tax Office will provide a tax incentive to encourage R&D activities in Australia, jointly administered by AusIndustry.

Companies with < $20m per annum turnover can be eligible for 45% refundable tax offset; and other companies can be eligible for a non-refundable 40% tax offset. Eligible companies can be Australian companies or non-Australian companies with an Australian entity. The R&D activities covered by this incentive generally need to be conducted in Australia.

In a regional or global clinical trial perspective – our services such as Scientific Advisory Services, Project Management, Data Management and Statistics will be covered under this incentive.

George Clinical offers you world leading academic expertise, backed by comprehensive quality operations. With this tax incentive, our talent and resources are now more accessible than ever. An information pack for this incentive is available here.